Literature DB >> 1159579

Colonization by Enterobacteriaceae of the respiratory tract of children with cystic fibrosis of the pancreas and their antibody response.

E J Seidmon, L L Mosovich, E Neter.   

Abstract

Of 72 patients with fibrosis, 49 harbored Enterobacteriaceae in the respiratory tract, including Escherichia coli, Klebsiella, and Enterobacter. Colonization by two to four genera was documented in 29 subjects. Staphylococcus aureus was recovered from 44 of these 49 patients. The distribution of serogroups of E. coli was similar to that seen in patients with urinary tract infection. Antibody response against the O antigens of the patients' own Enterobacteriaceae was documented in 29 of these 49 children and encountered more often in patients with severe disease. Colonization by Enterobacteriaceae in the absence of Pseudomonas aeruginosa was seen more frequently in children with the mild form of the illness.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1159579     DOI: 10.1016/s0022-3476(75)80814-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

Review 1.  The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis.

Authors:  O C Tablan; W J Martone; W R Jarvis
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

2.  Bacteriostasis of Escherichia coli by milk. II. Effect of bicarbonate and transferrin on the activity of infant feeds.

Authors:  J M Dolby; S Stephens; P Honour
Journal:  J Hyg (Lond)       Date:  1977-04

3.  Duration of antibody responses to common enterobacterial and O antigens of children with pyogenic peritonitis.

Authors:  E K Griffiths; T C Jewett
Journal:  Infection       Date:  1976       Impact factor: 3.553

4.  Clinical Outcomes Associated With Escherichia coli Infections in Adults With Cystic Fibrosis: A Cohort Study.

Authors:  B D Edwards; R Somayaji; J Greysson-Wong; C Izydorczyk; B Waddell; D G Storey; H R Rabin; M G Surette; M D Parkins
Journal:  Open Forum Infect Dis       Date:  2019-11-18       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.